4.6 Article

Aging-associated changes in hematopoiesis and leukemogenesis: What's the connection?

期刊

AGING-US
卷 3, 期 6, 页码 643-656

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/aging.100351

关键词

-

资金

  1. Department of Defense [BC087579]
  2. Leukemia and Lymphoma Society
  3. National Cancer Institute [R21-CA137262]
  4. [T32 AG000279-09]

向作者/读者索取更多资源

Aging is associated with a marked increase in a number of diseases, including many types of cancer. Due to the complex and multi-factorial nature of both aging and cancer, accurate deciphering of causative links between aging and cancer remains a major challenge. It is generally accepted that initiation and progression of cancers are driven by a process of clonal evolution. In principle, this somatic evolution should follow the same Darwinian logic as evolutionary processes in populations in nature: diverse heritable types arising as a result of mutations are subjected to selection, resulting in expansion of the fittest clones. However, prevalent paradigms focus primarily on mutational aspects in linking aging and cancer. In this review, we will argue that age-related changes in selective pressures are likely to be equally important. We will focus on aging-related changes in the hematopoietic system, where age-associated alterations are relatively well studied, and discuss the impact of these changes on the development of leukemias and other malignancies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Cell Biology

Decoy fitness peaks, tumor suppression, and aging

Kelly C. Higa, James DeGregori

AGING CELL (2019)

Article Biology

A generalized theory of a age-dependent carcinogenesis

Andrii Rozhok, James DeGregori

Article Hematology

TNF-α driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging

Pavel Davizon-Castillo, Brandon McMahon, Sonia Aguila, David Bark, Katrina Ashworth, Ayed Allawzi, Robert A. Campbell, Emilie Montenont, Travis Nemkov, Angelo D'Alessandro, Nathan Clendenen, Lauren Shih, Natalie A. Sanders, Kelly Higa, Allaura Cox, Zavelia Padilla-Romo, Giovanni Hernandez, Eric Wartchow, George D. Trahan, Eva Nozik-Grayck, Kenneth Jones, Eric Pietras, James DeGregori, Matthew T. Rondina, Jorge Di Paola

Article Oncology

Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors

Jennifer L. Guida, Tim A. Ahles, Daniel Belsky, Judith Campisi, Harvey Jay Cohen, James DeGregori, Rebecca Fuldner, Luigi Ferrucci, Lisa Gallicchio, Leonid Gavrilov, Natalia Gavrilova, Paige A. Green, Chamelli Jhappan, Ronald Kohanski, Kevin Krull, Jeanne Mandelblatt, Kirsten K. Ness, Ann O'Mara, Nathan Price, Jennifer Schrack, Stephanie Studenski, Olga Theou, Russell P. Tracy, Arti Hurria

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Evolutionary Biology

Somatic maintenance impacts the evolution of mutation rate

Andrii Rozhok, James DeGregori

BMC EVOLUTIONARY BIOLOGY (2019)

Editorial Material Oncology

Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus

Catherine Pham-Danis, James DeGregori

CANCER RESEARCH (2019)

Article Evolutionary Biology

The special issue on cancer and evolution: Lessons learned

James DeGregori

EVOLUTIONARY APPLICATIONS (2020)

Article Evolutionary Biology

Identifying key questions in the ecology and evolution of cancer

Antoine M. Dujon, Athena Aktipis, Catherine Alix-Panabieres, Sarah R. Amend, Amy M. Boddy, Joel S. Brown, Jean-Pascal Capp, James DeGregori, Paul Ewald, Robert Gatenby, Marco Gerlinger, Mathieu Giraudeau, Rodrigo K. Hamede, Elsa Hansen, Irina Kareva, Carlo C. Maley, Andriy Marusyk, Nicholas McGranahan, Michael J. Metzger, Aurora M. Nedelcu, Robert Noble, Leonard Nunney, Kenneth J. Pienta, Kornelia Polyak, Pascal Pujol, Andrew F. Read, Benjamin Roche, Susanne Sebens, Eric Solary, Katerina Stankova, Holly Swain Ewald, Frederic Thomas, Beata Ujvari

Summary: The integration of ecological and evolutionary principles into cancer research has become increasingly important in the past 50 years. It is crucial to broaden the research directions and stimulate novel approaches at the interface of oncology and ecological and evolutionary sciences. Effective cross-disciplinary collaborations among experts in ecology, evolution, and cancer are essential to address current and future questions about cancer.

EVOLUTIONARY APPLICATIONS (2021)

Article Immunology

Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors

Kelly C. Higa, Andrew Goodspeed, James S. Chavez, Marco De Dominici, Etienne Danis, Vadym Zaberezhnyy, Jennifer L. Rabe, Daniel G. Tenen, Eric M. Pietras, James DeGregori

Summary: The study found that chronic exposure to interleukin-113 (IL-113) can induce Cebpa loss, leading to increased myeloid lineage output. In addition, overexpression of the CEBPA gene may reduce the fitness of acute myeloid leukemias, resulting in increased differentiation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

Resilience integrates concepts in aging research

Daniel Promislow, Rozalyn M. Anderson, Marten Scheffer, Bernard Crespi, James DeGregori, Kelley Harris, Barbara Natterson Horowitz, Morgan E. Levine, Maria A. Riolo, David S. Schneider, Sabrina L. Spencer, Dario Riccardo Valenzano, Michael E. Hochberg

Summary: Aging research involves diverse disciplines, but lacks communication between them. Researchers propose that the concept of resilience can act as a bridge to connect these disciplines, thereby advancing research in the biology of aging.

ISCIENCE (2022)

Review Oncology

The sculpting of somatic mutational landscapes by evolutionary forces and their impacts on aging-related disease

Fabio Marongiu, James DeGregori

Summary: Aging is a major risk factor for cancer and other diseases. Recent studies have shown that aging leads to the accumulation of cancer-associated mutations in normal tissues, causing the formation of expanded clones. Additionally, aged tissue microenvironments promote the initiation and progression of malignancies.

MOLECULAR ONCOLOGY (2022)

Editorial Material Oncology

Dangerous Liaisons between Tet2 Mutation, Inflammatory Monocytes, and Leukemogenesis

Eric M. Pietras, James DeGregori

Summary: Transgenic knockin mice expressing a common loss-of-function mutation in human TET2 exhibit accelerated myeloid leukemia development related to aging, along with skewing of myelopoiesis towards the production of proinflammatory MHC-IIhi monocytes, suggesting a potential contribution to the disease.

CANCER DISCOVERY (2022)

Article Biology

Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation

Hae J. Park, Mark A. Gregory, Vadym Zaberezhnyy, Andrew Goodspeed, Craig T. Jordan, Jeffrey S. Kieft, James DeGregori

Summary: The bone marrow microenvironment provides protection to AML cells from FLT3 inhibitor drugs through the activation of ATM and upregulation of oxidative phosphorylation. Combination therapy with the mTOR inhibitor everolimus and the FLT3 inhibitor quizartinib effectively reduces tumor burden and prevents relapse in AML xenograft models.
Editorial Material Genetics & Heredity

Our ancestry dictates clonal architecture and skin cancer susceptibility

Marco De Dominici, James DeGregori

Summary: The incidence of keratinocyte skin cancer varies across different populations. A study comparing somatic mutations in the normal skin of individuals from the UK and Singapore shows distinct mutational landscapes that may contribute to differential risk.

NATURE GENETICS (2023)

暂无数据